Term
|
Definition
| 5-lipoxygenase inhibitor; inhibits leukotriene formation |
|
|
Term
| Indications of Roferon A? |
|
Definition
| AIDS related Kaposi’s sarcoma, hairy cell leukemia |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Antiplatelet effect, vasodilator, non-selective COX inhibitor |
|
|
Term
| Indications of Herceptin? |
|
Definition
|
|
Term
| Indications of Selzentry? |
|
Definition
| CCR5 tropic HIV-1 infection |
|
|
Term
|
Definition
| CMV reduction in kidney transplants |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Chronic granulomatous disease |
|
|
Term
| Indications of Digibind/DigiFab? |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Glucocorticoid/corticosteroid Inhibit leukocyte infiltration @ site of inflammation, interfere with mediators of inflammation, response and suppress humoral immune response |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Hep B and C, genital warts |
|
|
Term
| Indications of Cyclophosphamide? |
|
Definition
| Hodgkin’s lymphoma, Burkitt’s lymphoma, CLL, CML, AML, ALL |
|
|
Term
|
Definition
| Inhibit platelet aggregation in angioplasty |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Interferes with chemical mediators thrombin, plasmins and kallikrein. Broad spectrum protease inhibitor |
|
|
Term
|
Definition
| Mild to moderate atopic dermatitis |
|
|
Term
| Indications of Betaseron/Extavia? |
|
Definition
| Multiple Sclerosis, Hep B,C |
|
|
Term
|
Definition
| Platelet-activating factor receptor antagonist |
|
|
Term
| Indications of HyperHEP B, HBIG? |
|
Definition
|
|
Term
|
Definition
| Prevention of RSV(respiratory syncytial virus) in infants and children |
|
|
Term
| Indications of Prograf/Protopic? |
|
Definition
| Prevention of organ rejection during transplant; atopic dermatitis; GVHD |
|
|
Term
|
Definition
| Prevention of organ rejection in transplants |
|
|
Term
|
Definition
| Prevention of severe thrombocytopenia/chemotherapy for nonmyeloid malignancy |
|
|
Term
|
Definition
| Prophylaxis and chronic asthma |
|
|
Term
|
Definition
| Prophylaxis of organ rejection in patients receiving renal transplants (in combination with cyclosporine and corticosteroids) |
|
|
Term
| Indications of Rapamycin? |
|
Definition
| Prophylaxis of organ rejection in patients receiving renal transplants; GVHD |
|
|
Term
|
Definition
| Psoriasis; IL-12 inhibitor |
|
|
Term
|
Definition
|
|
Term
| Indications of Azasan/Imuran? |
|
Definition
|
|
Term
|
Definition
| RA, Crohn’s disease, psoriasis |
|
|
Term
|
Definition
| RA, Crohn’s disease, psoriasis |
|
|
Term
|
Definition
| RA, JIA, AS, and psoriasis |
|
|
Term
|
Definition
| RA, psoriatic arthritis, ankylosing spondylitis |
|
|
Term
|
Definition
|
|
Term
| Indications of Alferon-N? |
|
Definition
| Refractory genital warts, HIV/AIDS, Chronic Hep C |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| SSRI Antagonist @ 5-HT-2B |
|
|
Term
|
Definition
| Selective COX 2 inhibitor |
|
|
Term
|
Definition
| Selective COX 2 inhibitor |
|
|
Term
|
Definition
| Selective COX 2 inhibitor |
|
|
Term
|
Definition
| Selective Leu receptor antagonist inhibits the cysteinyl leu receptor. |
|
|
Term
| Indications of Rheumatrex/Trexall? |
|
Definition
| Stomach cancer, breast cancer and leukemia |
|
|
Term
| MOA of Baycadron/Maxidex/Ozurdex? |
|
Definition
| Suppression of neutrophil migration, decrease inflammatory mediators |
|
|
Term
|
Definition
| Synthetic corticosteroid Glucocorticoid receptor agonist |
|
|
Term
| Indications of Gammagard/Gamimune-N/Gammar-P? |
|
Definition
| Thrombocytopenia (ITP) immunodeficiency |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Thromboxane synthetase inhibitor |
|
|
Term
|
Definition
| Thromboxane synthetase inhibitor |
|
|
Term
|
Definition
| Trmt of Wilms’ tumor, testicular cancer |
|
|
Term
|
Definition
| inhibits production of thromboxane; anti-inflammatory and antirheumatic due to inhibition of syntheses and release of prostaglandins |
|
|
